| 1 |
NCT02633761 |
Recruiting |
Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death |
|
- Drug: Mifepristone
- Drug: Placebo
- Drug: Misoprostol 200mcg
|
Interventional |
Phase 3 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Complete uterine evacuation of the fetus and placenta without surgical intervention
|
200 |
Female |
18 Years to 64 Years (Adult) |
NCT02633761 |
1019 |
|
April 2015 |
June 2017 |
June 2017 |
December 17, 2015 |
July 18, 2016 |
|
- Hospital General "Enrique Cabrera"
Mexico City, Mexico - National Institute of Perinatology (INPer)
Mexico City, Mexico - National Ob-Gyn Hospital
Hanoi, Vietnam
|
| 2 |
NCT03214328 |
Not yet recruiting |
Causes of Fetal Death: Comparison of Diagnostic Accuracy Between Extensive and Selective Protocol Testing |
|
- Diagnostic Test: Determination of causes of fetal death
|
Observational |
|
- University Hospital, Rouen
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Concordance of the causes of fetal death between selective and systematic protocol testing
|
602 |
Female |
18 Years to 45 Years (Adult) |
NCT03214328 |
2014/209/HP |
EMIBICI |
September 2017 |
January 2021 |
January 2021 |
July 11, 2017 |
July 11, 2017 |
|
- Rouen University Hospital
Rouen, France
|
| 3 |
NCT02620904 |
Recruiting |
Mifepristone Induction for Fetal Demise |
- Intrauterine Fetal Demise
- Fetal Death
|
- Drug: Mifepristone
- Drug: placebo
|
Interventional |
Phase 4 |
- Montefiore Medical Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- time to delivery of fetus
|
74 |
Female |
16 Years and older (Child, Adult, Senior) |
NCT02620904 |
2015-5689 |
MIFD |
February 2016 |
September 2018 |
January 2019 |
December 3, 2015 |
October 17, 2016 |
|
- Montefiore Medical Center
Bronx, New York, United States
|
| 4 |
NCT00856076 |
Recruiting |
Venous Thromboembolism in Pregnancy Study |
- Venous Thromboembolism
- Intrauterine Fetal Death
|
|
Observational |
|
|
Other |
- Observational Model: Case Control
- Time Perspective: Retrospective
|
|
1200 |
Female |
18 Years and older (Adult, Senior) |
NCT00856076 |
VIP-study |
VIP |
January 2005 |
December 2010 |
December 2023 |
March 5, 2009 |
October 18, 2011 |
|
- Oslo University Hospital Ullevaal (formerly Ullevaal University Hospital)
Oslo, Norway - Oslo University Hospital (formerly Ullevaal University Hospital)
Oslo, Norway
|
| 5 |
NCT03067298 |
Recruiting |
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening |
- Preeclampsia
- Preterm Birth
- Fetal Growth Restriction
- Intra Uterine Fetal Death
|
|
Observational |
|
- Emmanuel Bujold
- Thermo Fisher Scientific
- Laval University
- CHU de Quebec-Universite Laval
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- preeclampsia
- Fetal growth restriction
- Preterm birth
- Intra uterine fetal death
|
1000 |
Female |
18 Years and older (Adult, Senior) |
NCT03067298 |
2017-3219 |
PREDICTION2 |
October 2016 |
March 2018 |
December 2018 |
March 1, 2017 |
July 24, 2017 |
|
- CHU de Quebec
Quebec, Canada
|
| 6 |
NCT03327766 |
Not yet recruiting |
Assesment of Vit D3 Level in Cases of Unexplaind Pregnancy Loss in Assiut |
- vitD3 Level in Cases of Recuurent Pregnancy Loss
|
- Diagnostic Test: 4-Measurment of serum 25(OH)D3 using Vidas by ELFA meathod.
|
Observational |
|
- Woman's Health University Hospital, Egypt
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
|
100 |
Female |
20 Years to 35 Years (Adult) |
NCT03327766 |
Vit D and RPL |
vitDinRPL |
November 1, 2017 |
April 30, 2018 |
October 31, 2018 |
October 31, 2017 |
October 31, 2017 |
|
|
| 7 |
NCT03054558 |
Recruiting |
JZ Thickness as a Predictor of Recurrent Unexplained First Trimesteric Pregnancy Loss. |
- Patients With Recurrent Unexplained Pregnancy Loss
|
- Other: Pelvic ultrasound both two dimensional and three dimentional
|
Observational |
|
- sherine Hosny Mohamed Gad Allah
- Cairo University
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Thickness of junctional zone
- Uterine artery Doppler Indices
- Subendometrial blood flow
- Endometrial thickness
|
100 |
Female |
18 Years to 35 Years (Adult) |
NCT03054558 |
C111 |
JZ |
December 2015 |
December 2018 |
April 2019 |
February 15, 2017 |
April 10, 2018 |
|
- Kasr AlAini teaching hospital
Cairo, Egypt
|
| 8 |
NCT03354832 |
Recruiting |
In-utero Death and Birth Mortality in Reunion Island |
- Pregnancy Loss
- Infant Death
|
- Other: Foetal death
- Other: New-born death
- Other: Birth control for foetal death
- Other: Birth control for new-born death
|
Observational |
|
- Centre Hospitalier Universitaire de la Réunion
|
Other |
- Observational Model: Other
- Time Perspective: Prospective
|
|
560 |
Female |
16 Years and older (Child, Adult, Senior) |
NCT03354832 |
2016/CHU/08 |
RAMIR |
March 14, 2017 |
March 2021 |
June 2021 |
November 28, 2017 |
November 28, 2017 |
|
- Chu Reunion Island
Saint-Pierre, Réunion
|
| 9 |
NCT03455387 |
Recruiting |
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy. |
- Pre-Eclampsia
- HELLP Syndrome
- Fetal Death
- (and 3 more...)
|
- Diagnostic Test: sampling of the serum marker sFlt1 and PlGF
|
Observational |
|
- Centre Hospitalier Metropole Savoie
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Arisen of a maternal and/or fetal severe complication
|
250 |
Female |
18 Years and older (Adult, Senior) |
NCT03455387 |
CHMS16001 |
PRECOPE |
January 10, 2017 |
March 10, 2020 |
April 10, 2020 |
March 6, 2018 |
March 6, 2018 |
|
- CHMetropoleSavoie
Chambéry, Savoie, France - Centre Hospitalier Alpes Léman
Contamine-sur-Arve, France - Centre Hospitalier Annecy Genevois
Metz-Tessy, France - Hôpitaux du Léman
Thonon-les-Bains, France
|
| 10 |
NCT03305263 |
Recruiting |
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss |
|
- Drug: Hydroxychloroquine
- Drug: Hydroxychloroquine placebo
|
Interventional |
Phase 3 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Live birth
- Live birth after exclusion of patients with a chromosomal abnormal pregnancy loss, extrauterine pregnancy loss, intended abortion or patients with insufficient intake of study medicine
- Birth weight
- (and 3 more...)
|
186 |
Female |
18 Years to 39 Years (Adult) |
NCT03305263 |
HCQDenmark
2016-004981-24 |
|
January 25, 2018 |
January 2021 |
January 2023 |
October 9, 2017 |
January 30, 2018 |
|
- Rigshospitalet
København, Denmark
|
| 11 |
NCT03209063 |
Not yet recruiting |
The Role of Prothrombin Gene Polymorphism as a Risk Factor for Recurrent Pregnancy Loss |
|
- Diagnostic Test: polymerase chain reaction
|
Observational |
|
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- percentage of recurrent pregnancy loss with the presence of prothrombin gene mutation in these women
|
100 |
Female |
18 Years to 45 Years (Adult) |
NCT03209063 |
TROPGP |
|
August 1, 2017 |
August 1, 2018 |
December 30, 2018 |
July 6, 2017 |
July 6, 2017 |
|
|
| 12 |
NCT03174951 |
Recruiting |
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss |
|
|
Interventional |
Phase 2 |
- Tabriz University of Medical Sciences
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes in NK cells frequency.
- Changes in secretion levels of cytokines related to Th17 cells(IL-17,IL-21)
- Changes in secretion The amount of autoantibodies
- (and 3 more...)
|
40 |
Female |
18 Years to 41 Years (Adult) |
NCT03174951 |
TabrizUMS-infertility-003 |
|
September 20, 2016 |
April 10, 2018 |
June 20, 2018 |
June 5, 2017 |
January 30, 2018 |
|
- Alzahra hospital
Tabriz, Iran, Islamic Republic of
|
| 13 |
NCT02990403 |
Recruiting |
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss |
|
- Drug: Aspirin
- Drug: Heparin
- Drug: Prednisone
- (and 2 more...)
|
Interventional |
Phase 4 |
- Shanghai First Maternity and Infant Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- live birth
- D-dimer
- Uterine artery blood flow
- human chorionic gonadotropin
|
500 |
Female |
18 Years to 50 Years (Adult) |
NCT02990403 |
ShanghaiFMIH-0003 |
|
October 2014 |
June 10, 2017 |
December 22, 2018 |
December 13, 2016 |
March 8, 2017 |
|
- Shanghai first Maternity and Infant health hospital, Tong Ji University
Shanghai, China
|
| 14 |
NCT01635426 |
Recruiting |
Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages |
|
- Drug: Aspirin
- Drug: Clopidogrel
|
Interventional |
Phase 2
Phase 3 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Improvement in uterine artery pulsatility index
- Improvement in subendometrial blood flow
|
32 |
Female |
20 Years to 35 Years (Adult) |
NCT01635426 |
ASUOGRCT976 |
|
March 2012 |
January 2018 |
March 2018 |
July 9, 2012 |
March 10, 2017 |
|
- Ain Shams University
Abbasiya, Cairo, Egypt
|
| 15 |
NCT03220750 |
Recruiting |
University Hospital Advanced Age Pregnant Cohort |
- Advanced Maternal Age Pregnancy
- High Risk Pregnancy
- Perinatal Death
- (and 4 more...)
|
|
Observational |
|
- Peking University
- Peking University Third Hospital
- Peking University First Hospital
- (and 8 more...)
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Incidence of major gestational complications and adverse pregnancy outcomes in pregnant women with the advanced age, for a singleton or twin and higher order multiple gestation
- Maternal death
- The rate of cesarean delivery
- (and 3 more...)
|
22000 |
Female |
35 Years to 60 Years (Adult) |
NCT03220750 |
2016YFC1000401 |
UNIHOPE |
March 28, 2017 |
December 31, 2020 |
December 31, 2020 |
July 18, 2017 |
July 18, 2017 |
|
- Peking University First Hospital
Beijing, China - Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, China - Peking University Third Hospital
Beijing, China - (and 6 more...)
|
| 16 |
NCT03439956 |
Not yet recruiting |
Obstetric Outcomes After Transvaginal Specimen Extraction in Gynecological Laparoscopy |
- Pregnancy Complications
- Delivery;Abnormal;Stillbirth
|
- Procedure: Transvaginal specimen extraction
|
Observational |
|
- Università degli Studi dell'Insubria
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Cesarean sections
- Operative deliveries
- Gestational age at deliveries
- Pregnancy complications
|
200 |
Female |
18 Years to 35 Years (Adult) |
NCT03439956 |
OUTSET-1 |
OUTSET-1 |
April 1, 2018 |
April 1, 2019 |
April 1, 2021 |
February 20, 2018 |
February 22, 2018 |
|
|
| 17 |
NCT03401918 |
Recruiting |
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility |
- Recurrent Pregnancy Loss
- Unexplained Infertility
|
- Diagnostic Test: Uterine ERA and microbiome testing
- Drug: Oral antibiotics and vaginal probiotics
|
Interventional |
Phase 2 |
- Stanford University
- Instituto Valenciano de Infertilidad, IVI VALENCIA
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Sequential Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- abnormal microbiome bacterial sequencing
- abnormal endometrial receptivity array
- normalized microbiome bacterial sequencing
- normalized endometrial receptivity array
|
300 |
Female |
18 Years to 45 Years (Adult) |
NCT03401918 |
40761 |
|
September 6, 2017 |
July 1, 2018 |
May 1, 2019 |
January 17, 2018 |
January 17, 2018 |
|
- Reproductive Endocrinology and Infertility Center at Stanford University
Sunnyvale, California, United States
|
| 18 |
NCT03100123 |
Recruiting |
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study |
- Antiphospholipid Syndrome in Pregnancy
- Pregnancy Loss
|
- Drug: Aspirin 81 mg
- Drug: Low-molecular-weight heparin
|
Interventional |
Early Phase 1 |
- Ottawa Hospital Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Feasibility
- Essential Documents
- Eligibility
- (and 5 more...)
|
24 |
Female |
18 Years and older (Adult, Senior) |
NCT03100123 |
CTO 0807 |
APPLE |
November 6, 2017 |
November 6, 2019 |
January 2020 |
April 4, 2017 |
November 21, 2017 |
|
- McMaster University Medical Centre
Hamilton, Ontario, Canada - Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
|
| 19 |
NCT03433989 |
Not yet recruiting |
ACTRAMAT-D: Impact of Post-Traumatic Stress Disorder After Pregnancy Loss After 12 Weeks of Gestation |
|
- Diagnostic Test: telephone interview
|
Interventional |
Not Applicable |
- University Hospital, Angers
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Assessment of short-term post-traumatic stress disorder in women with fetal loss after 12 weeks of gestation with IES-R scale recorded at 30 days after fetal loss.
|
100 |
Female |
18 Years and older (Adult, Senior) |
NCT03433989 |
2017-AO-2588-45 |
ACTRAMAT-D |
February 15, 2018 |
May 15, 2019 |
August 15, 2019 |
February 15, 2018 |
February 15, 2018 |
|
|
| 20 |
NCT03438110 |
Not yet recruiting |
Asia Pregnancy Outcomes Study |
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Cause of Death
- Neonatal Death
- Preterm Death and Stillbirth Placental Pathology
- Stillbirth and Preterm Death Pathogens
|
1400 |
Female |
14 Years to 45 Years (Child, Adult) |
NCT03438110 |
CP COD |
|
May 2018 |
October 2020 |
October 2021 |
February 19, 2018 |
February 19, 2018 |
|
- J.J.M. Medical College Hospitals
Davangere, India - Jinnah Postgrad Medical Center
Karachi, Pakistan - National Institute of Child Health
Karachi, Pakistan
|
| 21 |
NCT03231007 |
Recruiting |
Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study |
|
|
Observational |
|
- University of Manchester
- Taunton and Somerset NHS Foundation Trust
- Royal Devon and Exeter NHS Foundation Trust
- (and 18 more...)
|
Other |
- Observational Model: Other
- Time Perspective: Cross-Sectional
|
- Stillbirths
- Term, normally formed singleton stillbirths (antepartum and intrapartum).
- Preterm births
- (and 11 more...)
|
4000 |
All |
16 Years and older (Child, Adult, Senior) |
NCT03231007 |
R04666 |
SPiRE |
July 10, 2017 |
December 31, 2017 |
March 31, 2018 |
July 27, 2017 |
October 31, 2017 |
|
- Barnsley Hospital NHS Foundation Trust
Barnsley, United Kingdom - Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom - Birmingham Women's and Children's NHS Foundation Trust
Birmingham, United Kingdom - (and 17 more...)
|
| 22 |
NCT03154866 |
Not yet recruiting |
Lactobacillus Kefiri LKF01 (DSM32079) in Newborns Born by Caesarian Section |
- Caesarean Section;Stillbirth
- Microbial Colonization
|
- Dietary Supplement: Lactobacillus kefiri LKF01 DSM32079
- Dietary Supplement: Placebo
|
Interventional |
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Presence of Lactobacillus kefiri LKF01 DSM32079 (LKEF) in fecal sample
- Number of participants with treatment-related adverse event
|
60 |
All |
up to 4 Months (Child) |
NCT03154866 |
KEFINEO1 |
|
June 1, 2017 |
December 31, 2017 |
June 30, 2018 |
May 16, 2017 |
May 18, 2017 |
|
- Dept Of Obstetrics and Neonatology - Section of Neonatology University of Bari Policlinico Hospital
Bari, Italy
|
| 23 |
NCT02907242 |
Recruiting |
Revealed Versus Concealed Cerebroplacental Ratio |
|
|
Interventional |
Not Applicable |
- Hospital Clinic of Barcelona
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Stillbirth
- Adverse perinatal outcome
- Fetal Growth Restriction Detection
|
11582 |
Female |
18 Years to 50 Years (Adult) |
NCT02907242 |
RATIO37 |
|
May 2016 |
May 2018 |
January 2019 |
September 20, 2016 |
September 20, 2016 |
|
- Hospital Clínico Universitario de Santiago de Chile
Santiago de Chile, Chile - Palacky University Hospital
Olomouc, Czech Republic - Hospital de Querétaro
Querétaro, Mexico - (and 2 more...)
|
| 24 |
NCT03363308 |
Recruiting |
Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa |
- Maternal Death
- Infant Death
- Stillbirth
|
- Behavioral: training for health care workers supplmented by QI teams
|
Interventional |
Not Applicable |
- Jhpiego
- Bill and Melinda Gates Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Mean number or percent of items correctly answered
- Intrapartum perinatal death ratio
- Percent of women after childbirth who adopt a family planning method immediately post-pregnancy or intend to adopt a method by six weeks post-pregnancy.
- maternal mortality
|
250 |
All |
18 Years and older (Adult, Senior) |
NCT03363308 |
OPP1156220 |
|
November 16, 2017 |
October 31, 2019 |
December 31, 2019 |
December 6, 2017 |
December 6, 2017 |
|
- Jhpiego DRC
Kinshasa, Congo, The Democratic Republic of the
|
| 25 |
NCT01888380 |
Recruiting |
The Paediatric Virtual Autopsy Trial |
- Stillbirth
- Newborn Death
- Sudden Infant Death
|
- Procedure: Minimally invasive, virtual autopsy
- Procedure: Conventional autopsy
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Percentage of cases for which virtual autopsy correctly identifies the cause of death and/or major pathological lesions
- Clinical indication
- MR Protocol
- Change in the ante-mortem diagnosis
|
100 |
All |
up to 16 Years (Child) |
NCT01888380 |
Paediatric virtopsy |
|
January 2014 |
December 2017 |
June 2018 |
June 27, 2013 |
May 3, 2017 |
|
- University Hospital Zurich, Division of Neonatology
Zurich, ZH, Switzerland - Division of obstetrics, University Hospital Zurich
Zurich, Switzerland - University Children's Hospital Zurich
Zurich, Switzerland - Zurich Institute for Forensic Medicine
Zurich, Switzerland
|
| 26 |
NCT03214185 |
Recruiting |
Effects of PGS2.0 in Patients With Unexplained RPL |
- Recurrent Pregnancy Loss
- Infertility, Female
|
- Procedure: IVF/ICSI
- Genetic: PGS 2.0
- Other: Conventional embryo morphology evaluation
|
Interventional |
Not Applicable |
- ShangHai Ji Ai Genetics & IVF Institute
- The International Peace Maternity & Child Health Hospital of China welfare institute
- Renji Hospital, Shanghai Jiao Tong University School of Medicine
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Live birth rate per initiated cycle
- Embryo implantation
- Clinical pregnancy
- (and 3 more...)
|
710 |
Female |
20 Years to 37 Years (Adult) |
NCT03214185 |
JIAI E2017-15 |
|
February 6, 2018 |
September 30, 2020 |
September 30, 2021 |
July 11, 2017 |
February 6, 2018 |
|
- Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital, Fudan University
Shanghai, Shanghai, China
|
| 27 |
NCT03112018 |
Recruiting |
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda |
- Pregnancy Complications
- Preterm Labor
- PreTerm Birth
- (and 2 more...)
|
- Behavioral: data strengthening
- Behavioral: modified Safe childbirth checklist - control
- Behavioral: modified Safe childbirth checklist - enhanced
- (and 2 more...)
|
Interventional |
Not Applicable |
- University of California, San Francisco
- Makerere University
- Kenya Medical Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- all-cause neonatal mortality among preterms/low birth weight newborns
- Data quality of key indicators in facility-based registers
- Pre-hospital discharge mortality among preterm infants and babies born alive between 500 and 999 grams at birth
- (and 4 more...)
|
123000 |
All |
Child, Adult, Senior |
NCT03112018 |
A123218-K/U |
PTBi-KE-UG |
July 2016 |
February 2019 |
April 2019 |
April 13, 2017 |
December 15, 2017 |
|
- Health facilities in Migori County: Rongo, Kehancha, Uriri, Kegonga, Karungu, Tisinye, Isibania, Macalder, Awendo, Ntimaru, Muhuru, Bugumbe, Nyamaraga, Othoro, St. Joseph, St. Camillus, Migori County Referral Hospital
Migori County, Kenya - Health facilities in Busoga Region: Bugiri, Buluba, Iganga, Kamuli Government, Kamuli Mission, Jinja Regional Referral Hospital
Busoga Region, Uganda
|
| 28 |
NCT02738892 |
Recruiting |
Zambian Prematurity Prevention Study |
- Pregnancy
- Stillbirth
- Preterm Birth
|
|
Observational |
|
- University of North Carolina, Chapel Hill
- Global Alliance to Prevent Prematurity and Stillbirth
- Bill and Melinda Gates Foundation
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Rate of preterm births per 100 person years
|
4000 |
Female |
18 Years to 50 Years (Adult) |
NCT02738892 |
14-2113 |
|
August 2015 |
June 2018 |
January 2019 |
April 14, 2016 |
February 7, 2018 |
|
- Kamwala Health Centre
Lusaka, Zambia - University Teaching Hospital
Lusaka, Zambia
|
| 29 |
NCT01653392 |
Recruiting |
BioThrax® (Anthrax) Vaccine in Pregnancy Registry |
- Pregnancy Complications
- Pregnancy Outcome
- Congenital Abnormalities
|
- Biological: Observational Intervention
|
Observational |
|
- Emergent BioSolutions
- Naval Health Research Center
|
Industry / U.S. Fed |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Pregnancy Outcomes
- Maternal Outcomes
- Infant Outcomes
|
580 |
Female |
Child, Adult, Senior |
NCT01653392 |
EBS.AVA.010 / NHRC.2012.0003 |
|
July 2012 |
June 2022 |
June 2022 |
July 31, 2012 |
February 5, 2018 |
|
- Naval Health Research Center
San Diego, California, United States
|
Create an RSS feed from your search for:
Download the search results for: